ProfileGDS4095 / 226104_at
TitleTamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OrganismHomo sapiens


SRC1 knockdown control tamoxifen untreated tamoxifen untreated GSM709767 GSM709769 GSM709765 GSM709771 GSM709772 GSM709775 GSM709764 GSM709766 GSM709768 GSM709777 GSM709770 GSM709773 GSM709774 GSM709776 76% 76% 76% 76% 76% 76% 75% 75% 75% 76% 75% 76% 75% 75% sort by genotype/variation sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM709767LY2 SRC1-siRNA tamoxifen treated rep18.1015276
GSM709769LY2 SRC1-siRNA tamoxifen treated rep38.0195876
GSM709765LY2 SRC1-siRNA untreated rep38.0781676
GSM709771LY2 SRC1-siRNA untreated rep18.0010176
GSM709772LY2 SRC1-siRNA untreated rep28.0785276
GSM709775LY2 SRC1-siRNA untreated rep48.064776
GSM709764LY2 control-siRNA tamoxifen treated rep27.8510875
GSM709766LY2 control-siRNA tamoxifen treated rep37.8398775
GSM709768LY2 control-siRNA tamoxifen treated rep17.8599875
GSM709777LY2 control-siRNA tamoxifen treated rep47.9992676
GSM709770LY2 control-siRNA untreated rep37.8629475
GSM709773LY2 control-siRNA untreated rep17.9731176
GSM709774LY2 control-siRNA untreated rep27.7491875
GSM709776LY2 control-siRNA untreated rep47.8742675